These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22234255)

  • 1. Is ulceration in cutaneous melanoma just a prognostic and predictive factor or is ulcerated melanoma a distinct biologic entity?
    Eggermont AM; Spatz A; Lazar V; Robert C
    Curr Opin Oncol; 2012 Mar; 24(2):137-40. PubMed ID: 22234255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.
    McMasters KM; Edwards MJ; Ross MI; Reintgen DS; Martin RC; Urist MM; Noyes RD; Sussman JJ; Stromberg AJ; Scoggins CR
    Ann Surg; 2010 Sep; 252(3):460-5; discussion 465-6. PubMed ID: 20739846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma.
    In 't Hout FE; Haydu LE; Murali R; Bonenkamp JJ; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jun; 255(6):1165-70. PubMed ID: 22566014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity.
    Eggermont AM; Suciu S; Rutkowski P; Kruit WH; Punt CJ; Dummer R; Salès F; Keilholz U; de Schaetzen G; Testori A;
    Eur J Cancer; 2016 Mar; 55():111-21. PubMed ID: 26790144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of ulceration of cutaneous melanoma of the head and neck: a comparison of ear (pinna) and nonear sites.
    Augenstein AC; Capello ZJ; Little JA; McMasters KM; Bumpous JM
    Laryngoscope; 2012 Nov; 122(11):2468-72. PubMed ID: 23108883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991.
    Eggermont AM; Suciu S; Testori A; Kruit WH; Marsden J; Punt CJ; Santinami M; Salès F; Schadendorf D; Patel P; Dummer R; Robert C; Keilholz U; Yver A; Spatz A
    Eur J Cancer; 2012 Jan; 48(2):218-25. PubMed ID: 22056637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of extent of ulceration in primary cutaneous melanoma.
    Grande Sarpa H; Reinke K; Shaikh L; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M
    Am J Surg Pathol; 2006 Nov; 30(11):1396-400. PubMed ID: 17063079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of ulceration of cutaneous melanoma.
    Balch CM; Wilkerson JA; Murad TM; Soong SJ; Ingalls AL; Maddox WA
    Cancer; 1980 Jun; 45(12):3012-7. PubMed ID: 7388745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
    Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS
    Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
    Zogakis TG; Essner R; Wang HJ; Foshag LJ; Morton DL
    Ann Surg Oncol; 2007 May; 14(5):1604-11. PubMed ID: 17333418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
    Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
    Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Incipient Ulceration in Primary Cutaneous Melanoma.
    Paver EC; Ahmed T; Burke H; Saw RPM; Stretch JR; Spillane AJ; Shannon KF; Vergara IA; Elder DE; Lo SN; Thompson JF; Scolyer RA
    JAMA Dermatol; 2023 Dec; 159(12):1359-1367. PubMed ID: 37910123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in patients with thick cutaneous melanoma (> 4 mm).
    Zettersten E; Sagebiel RW; Miller JR; Tallapureddy S; Leong SP; Kashani-Sabet M
    Cancer; 2002 Feb; 94(4):1049-56. PubMed ID: 11920475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials.
    Joosse A; Collette S; Suciu S; Nijsten T; Lejeune F; Kleeberg UR; Coebergh JW; Eggermont AM; de Vries E
    J Clin Oncol; 2012 Jun; 30(18):2240-7. PubMed ID: 22547594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
    Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
    J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.